These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 81906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Blood coagulation and fibrinolysis inhibitory factors].
    Imaoka S, Sasaki Y, Terasawa T.
    Rinsho Byori; 1985 Jun; Spec No 63():55-61. PubMed ID: 2413229
    [No Abstract] [Full Text] [Related]

  • 4. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK, Schmaier AH, Colman RW.
    Pathobiol Annu; 1982 Jun; 12():35-64. PubMed ID: 6186978
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ACL automated method for plasma inhibitors.
    Creter D.
    Haematologica; 1990 Jun; 75(6):582. PubMed ID: 1711504
    [No Abstract] [Full Text] [Related]

  • 7. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T.
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
    Lebreton de Vonne T, Mouray H.
    Int J Biochem; 1980 Jul; 12(3):479-84. PubMed ID: 6158467
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The biochemistry and pathophysiology of the contact system of plasma.
    Cochrane CG, Griffin JH.
    Adv Immunol; 1982 Jul; 33():241-306. PubMed ID: 6182767
    [No Abstract] [Full Text] [Related]

  • 13. Circulating anticoagulants: physiologic and pathophysiologic.
    Bussel JB.
    Hosp Pract (Off Ed); 1983 Feb; 18(2):169-72, 179-83, 186. PubMed ID: 6185409
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B, Bouissou F, Abbal M, Sie P, Caranobe C, Barthe P.
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [Abstract] [Full Text] [Related]

  • 16. Major inhibitors of the contact phase coagulation factors.
    Schapira M.
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood levels of proteinase inhibitors in pregnancy.
    Walker JE, Campbell DM, Ogston D.
    Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical significance of the natural inhibitors to coagulation and fibrinolysis in cases of renal diseases (author's transl)].
    Nakamura K, Kazama M.
    Rinsho Ketsueki; 1978 Jul; 19(7):934-9. PubMed ID: 81328
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.